EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 273 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $19,388,000 | -12.3% | 383,787 | +2.9% | 0.02% | -25.0% |
| Q4 2018 | $22,111,000 | -5.3% | 372,983 | +5.2% | 0.03% | +18.5% |
| Q3 2018 | $23,340,000 | +35.3% | 354,560 | +3.8% | 0.03% | +28.6% |
| Q2 2018 | $17,247,000 | -1.7% | 341,590 | +2.6% | 0.02% | -4.5% |
| Q1 2018 | $17,537,000 | +13.8% | 333,083 | +0.4% | 0.02% | +15.8% |
| Q4 2017 | $15,417,000 | +3773.6% | 331,758 | +3271.5% | 0.02% | – |
| Q3 2017 | $398,000 | -5.7% | 9,840 | -21.1% | 0.00% | -100.0% |
| Q2 2017 | $422,000 | +15.9% | 12,471 | -0.7% | 0.00% | – |
| Q1 2017 | $364,000 | +8.7% | 12,558 | +23.0% | 0.00% | – |
| Q4 2016 | $335,000 | +14.3% | 10,207 | +9.9% | 0.00% | – |
| Q3 2016 | $293,000 | +20.1% | 9,284 | +38.4% | 0.00% | – |
| Q1 2016 | $244,000 | -21.0% | 6,706 | -13.1% | 0.00% | – |
| Q4 2015 | $309,000 | – | 7,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |